Revisions Larimar Therapeutics, Inc.

Equities

LRMR

US5171251003

Real-time Estimate Cboe BZX 11:42:24 2024-06-10 am EDT 5-day change 1st Jan Change
9.835 USD +2.55% Intraday chart for Larimar Therapeutics, Inc. +7.55% +116.04%

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. LRMR Stock
  4. Revisions Larimar Therapeutics, Inc.